Krembil Research Institute


The Krembil Research Institute, formerly known as the Toronto Western Research Institute, is a non-profit academic medical research institute located in Canada's largest city, Toronto. The Krembil is one the principal research institutes of the University Health Network of academic teaching hospitals associated with the University of Toronto; the Krembil is also one of the largest research institutes in Canada focusing on human neurological disease from both a basic science and clinical research perspective. Research within the Krembil is directed at the development of treatments for neurodegenerative diseases, epilepsy, stroke, brain tumours, concussions, spinal cord injuries, neurophthalmologic and other ocular disorders, multiple sclerosis and autoimmune disorders.
The University Health Network is Canada's largest academic medical centre, comprising four major teaching hospitals and a strategic alliance with the Toronto Mount Sinai Hospital. The Krembil is the research institute of the Toronto Western Hospital and fulfills the mandate for neuroscience and musculoskeletal health research within the UHN academic medical centre. In total, UHN devotes C$160 million a year to research and trains more than 3,200 undergraduate, graduate and medical students at its member hospitals and institutes in association with the University of Toronto. The University of Toronto is Canada's largest university and one of the biggest in North America, consistently ranking in the top 25 universities internationally in the Times Higher Education World University Rankings, the Academic Ranking of World Universities and the QS World University Rankings.

History

In 1895, twelve physicians in the west end of Toronto united to create the Toronto Western Hospital in order to serve an overlooked culturally-diverse neighbourhood in Toronto. The Toronto Western Hospital first opened as a medication dispensary, followed by a 30-bed general hospital temporarily functioning out of two rented houses. By 1899 sufficient money was raised to purchase a nearby farmhouse and to build the Western on its present site. During construction, patients were treated year-round under large tents until the hospital officially opened in 1905. Throughout the 20th century, the Toronto Western Hospital functioned as a general hospital serving clients from culturally- and economically-diverse backgrounds. In the early 1980s, the Western took on additional neurological and neurosurgical care responsibilities for the UHN group of hospitals. Concomitant with this new clinical care focus, strength in applied neuroscience research began to emerge. In 1980, the Playfair Neuroscience Institute was created at the TWH to capitalize on this evolving neuroscience focus. In 1999, the Playfair Neuroscience Institute was renamed the Toronto Western Research Institute as it joined the Toronto General Research Institute and the Princess Margaret Research Institute as the three main hospital-based institutes within UHN. After this change, the Krembil also took on additional areas of research interest including ophthalmology, rheumatology and orthopaedics. By 2004, under the founding leadership of neurosurgeon C. Wallace, the Krembil had emerged as one of the largest research institutes in Canada with a neuroscience emphasis.
On November 13, 2015, the Krembil took on its current name; prior to November 13, 2015, the Krembil was known as the Toronto Western Research Institute. The Krembils are among Canada's leading investors in neuroscience research. The impact at Toronto Western alone is $80 million, including the nine-storey, state-of-the-art Krembil Discovery Tower, which opened in 2013.

Research Activities

Krembil scientists are at work on a diverse array of human healthcare questions within multiple research programs. At the Krembil, neuroscientists explore the function of the nervous system as they develop treatments for neurodegenerative diseases such as Alzheimer's disease and Parkinson's disease, epilepsy, spinal cord injuries, cerebral ischemia, vascular brain malformations, aneurysms, brain tumours and pain disorders. The Krembil is also home to the Vision Science Research Program, a joint UHN/University of Toronto Program. This research is directed into the following areas: molecular genetics of blinding eye diseases with brain disorders; treatment and biophysics of glaucoma; eye movement control mechanisms; neuronal damage; retinal degeneration and diabetic retinopathy. Arthritis and associated rheumatological degenerative diseases are the focus of the researchers in the musculoskeletal research program at the Krembil as part of the UHN Arthritis and Autoimmunity Research Centre. Their investigations are aimed at revealing the causes of, and generating therapies for, these autoimmune and orthopaedic ailments.

Historical Research Achievements of the Krembil and UHN Neuroscience

1980-1988 – William Tatton
1988-1990 – Charles Tator
1990-1999 – Peter Carlen
1999-2004 – Christopher Wallace
2004-2011 – Peter St George-Hyslop
2011-2013 – Peter Carlen
2013–present – Donald Weaver
Christopher Wallace MD, MSc, FRCSC, a neurosurgeon and neurophysiologist, was the first official director of the Krembil; his research focussed on therapeutic approaches to vascular brain injury. Peter St George-Hyslop MD, PhD, FRCPC, a neurologist and PhD geneticist, was the second full-time director of the Krembil; his research focussed on the genetic basis of neurodegenerative diseases such as Alzheimer's dementia.

Facilities

Since its inception, the Krembil has been co-located with the Toronto Western Hospital at the corner of Bathurst Street and Dundas Street West in Toronto, Canada. Within this location, the Krembil occupies dedicated to a full range of basic science, clinical, imaging and epidemiological research. In 2013, the Krembil expands into an additional of space, spanning nine floors, in the newly constructed Krembil Discovery Tower attached to the TWH. The Krembil Discovery Tower space includes of "wet" laboratory bench space for Krembil basic science researchers.
In 2011, the Krembil was home to 122 biomedical researchers, 206 technical/support staff and 157 research trainees, who collectively produced 515 peer-reviewed publications supported by more than $43,612,000 of external research funding.
In addition to conventional peer-review funding, the Krembil receives support from the Toronto General/Toronto Western Hospital Foundation which is currently embarked upon a $200 million "Brain Campaign" to support neuroscience research within the Krembil. The campaign has raised over $273 million as of January 2016 through the leadership of Dr Gerald Halbert and Todd Helpern Co-Chairs and Campaign Director Douglas Earle.

Strategic Research Alliances

The Krembil has many strategic research alliances, nationally and internationally, to facilitate and enhance the delivery of its research mandate. Two of the notable strategic research alliances are as follows: